# OnCo record century-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/century-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "century-therapeutics" ;
  schema:name "Century Therapeutics"@en ;
  schema:description "Century makes off-the-shelf cell therapies from induced pluripotent stem cells that are engineered to hide from the patient's immune system. Its main focus is now type 1 diabetes, with a CD19 CAR T-like product for cancer and autoimmune disease due to enter the clinic in 2026."@en ;
  schema:url <https://onco.cc/companies/century-therapeutics/>, <https://www.centurytx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.centurytx.com/>, <https://www.sec.gov/Archives/edgar/data/1850119/000110465926094533/tm2622911d1_ex99-1.htm> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> .
